Your browser doesn't support javascript.
loading
Follow Your Nose: Repeat Nasal Bone Evaluation in First-Trimester Screening for Down Syndrome.
Miller, Kristen A; Sagaser, Katelynn G; Hertenstein, Christine B; Blakemore, Karin J; Forster, Katherine R; Lawson, Cathleen S; Jelin, Angie C.
Afiliação
  • Miller KA; Division of Maternal Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, Maryland, USA.
  • Sagaser KG; Juno Diagnostics, San Diego, California, USA.
  • Hertenstein CB; Division of Maternal Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, Maryland, USA.
  • Blakemore KJ; Division of Maternal Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, Maryland, USA.
  • Forster KR; Division of Maternal Fetal Medicine, Sibley Memorial Hospital, Johns Hopkins Medicine, Washington, DC, USA.
  • Lawson CS; Division of Maternal Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, Maryland, USA.
  • Jelin AC; Division of Maternal Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, Maryland, USA.
J Ultrasound Med ; 42(8): 1709-1716, 2023 Aug.
Article em En | MEDLINE | ID: mdl-36744578
ABSTRACT

OBJECTIVE:

Examine whether repeat nasal bone evaluation following an absent/uncertain nasal bone on first-trimester screening (FTS) improves Down syndrome (DS) screening specificity.

METHODS:

A retrospective chart review of FTS sonograms in one center from January 2015 to January 2018 was performed. Data was extracted for those with an absent/uncertain nasal bone. Repeat evaluations were offered.

RESULTS:

Of 6780 FTS sonograms, 589 (8.7%) had an absent/uncertain nasal bone. Upon repeat exam, 268/376 (71.3%) had a present nasal bone. Compared with Black patients, patients of other ethnicities were more likely to have a present nasal bone on exam 2 (P < .00001). Of 268 patients with a present nasal bone on exam 2, 37 (13.8%) had an abnormal DS risk following exam 1; 34/37 (91.9%) normalized following nasal bone visualization, dropping the screen positive rate to 1.1%.

CONCLUSION:

Repeat nasal bone examination is beneficial in refining DS risk assessment and improves the specificity of FTS.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Down Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: J Ultrasound Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Down Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: J Ultrasound Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos